Led by Questa Capital, the Series B will fund an expansion of the EnsoData growth team, driving adoption of AI solutions that streamline the diagnosis and monitoring of the estimated 1 billion people living with sleep apnea worldwide
EnsoData™, an innovator in AI solutions in sleep medicine, adds Bobby Cockrill, MBA, as Chief Commercial Officer, (CCO) to oversee strategy and execution of sales and marketing functions, grow a world-class team, and continue accelerating adoption across North America.
EnsoData’s AI solutions allow BetterNight to scale operations by more than 2X, (growing home testing to ~1,500 studies with just two scoring technologists, resulting in increased top and bottom-line revenue increases and enhanced clinical efficacy.
EnsoData, BodiMetrics announce collaboration to expedite sleep testing, expand long-term patient monitoring. BodiMetrics’ FDA-cleared circul pro™ ring, paired with EnsoHST advanced AI/ML analysis, offers accessible, comfortable home sleep testing.
Happy Health partnership aims to reduce barriers to care by putting patients in control of their own health journey and enabling nightly monitoring to enhance early stage detection using the Happy Ring and Happy Sleep platform, powered by EnsoData’s EnsoHST AI algorithm for scoring and analysis of the sleep data.
From technologists, to lab managers, to owners and directors, EnsoSleep Study Management offers sleep teams a single cloud-based platform to view, edit, and report on
See how Total Sleep Time can improve confidence in results generated from your sleep clinic’s home sleep apnea testing (HSAT) program If you’re reading this